- Report
- October 2024
- 191 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- January 2024
- 131 Pages
Global
From €3500EUR$3,921USD£3,032GBP
- Report
- October 2024
- 270 Pages
China
From €3824EUR$4,000USD£3,201GBP
- Report
- October 2024
- 135 Pages
China
From €1721EUR$1,800USD£1,441GBP
Cefaclor is a cephalosporin antibiotic used to treat a variety of respiratory infections, including bronchitis, pneumonia, and sinusitis. It is also used to treat ear, throat, and urinary tract infections. Cefaclor is available in both oral and intravenous forms. It is generally well tolerated, with few side effects.
Cefaclor is a popular choice for treating respiratory infections due to its broad spectrum of activity and low cost. It is often prescribed as a first-line treatment for mild to moderate infections. It is also used in combination with other antibiotics to treat more severe infections.
The cefaclor market is highly competitive, with many generic and branded products available. Major players in the market include Pfizer, GlaxoSmithKline, Merck, and Sanofi. Other companies include Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more